The development of therapeutic and preventive vaccines for gastric cancer and Helicobacter pylori

被引：8

作者：

Chui, SY ^{[1
]}

Clay, TM ^{[1
]}

Lyerly, HK ^{[1
]}

Morse, MA ^{[1
]}

机构：

[1] Duke Univ, Med Ctr, Durham, NC 27710 USA

来源：

CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION | 2005年 / 14卷 / 08期

关键词：

D O I：

10.1158/1055-9965.EPI-04-0775

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 [肿瘤学];

摘要：

Gastric cancer is one of the most important worldwide public health problems. Convincing epidemiologic and etiologic associations have been made between the development of gastric cancer and infection with Helicobacter pylori. H. pylori not only has adapted to survive within the harsh environment of the stomach but also is able to modulate and avoid endogenous immune responses. The design and creation of efficacious vaccine strategies against H. pylori requires an understanding of the complex interactions that make up mucosal immunity. An effective vaccine strategy against H. pylori has the potential to affect significantly on population health worldwide.

引用

收藏

页码：1883 / 1889

页数：7

相关论文

共 82 条

[1]

PCR-BASED RFLP ANALYSIS OF DNA-SEQUENCE DIVERSITY IN THE GASTRIC PATHOGEN HELICOBACTER-PYLORI [J].

AKOPYANZ, N ;

BUKANOV, N ;

WESTBLOM, TU ;

BERG, DE .

NUCLEIC ACIDS RESEARCH, 1992, 20 (23) :6221-6225

[2]

Virulent strains of Helicobacter pylori demonstrate delayed phagocytosis and stimulate homotypic phagosome fusion in macrophages [J].

Allen, LAH ;

Schlesinger, LS ;

Kang, B .

JOURNAL OF EXPERIMENTAL MEDICINE, 2000, 191 (01) :115-127

[3]

Density of Helicobacter pylori infection in vivo as assessed by quantitative culture and histology [J].

Atherton, JC ;

Tham, KT ;

Peek, RM ;

Cover, TL ;

Blaser, MJ .

JOURNAL OF INFECTIOUS DISEASES, 1996, 174 (03) :552-556

[4]

Lymphocytes in the human gastric mucosa during Helicobacter pylori have a T helper cell 1 phenotype [J].

Bamford, KB ;

Fan, XJ ;

Crowe, SE ;

Leary, JF ;

Gourley, WK ;

Luthra, GK ;

Brooks, EG ;

Graham, DY ;

Reyes, VE ;

Ernst, PB .

GASTROENTEROLOGY, 1998, 114 (03) :482-492

[5]

Safety and efficacy of low dose Escherichia coli enterotoxin adjuvant for urease based oral immunisation against Helicobacter pylori in healthy volunteers [J].

Banerjee, S ;

Medina-Fatimi, A ;

Nichols, R ;

Tendler, D ;

Michetti, M ;

Simon, J ;

Kelly, CP ;

Monath, TP ;

Michetti, P .

GUT, 2002, 51 (05) :634-640

[6]

Synthesis and activity of Helicobacter pylori urease and catalase at low pH [J].

Bauerfeind, P ;

Garner, R ;

Dunn, BE ;

Mobley, HLT .

GUT, 1997, 40 (01) :25-30

[7]

Expression of Fas ligand by human gastric adenocarcinomas: a potential mechanism of immune escape in stomach cancer [J].

Bennett, MW ;

O'Connell, J ;

O'Sullivan, GC ;

Roche, D ;

Brady, C ;

Kelly, J ;

Collins, JK ;

Shanahan, F .

GUT, 1999, 44 (02) :156-162

[8]

Severe inflammation and reduced bacteria load in murine Helicobacter infection caused by lack of phagocyte oxidase activity [J].

Blanchard, TG ;

Yu, FW ;

Hsieh, CL ;

Redline, RW .

JOURNAL OF INFECTIOUS DISEASES, 2003, 187 (10) :1609-1615

[9]

The Helicobacter pylori vacuolating toxin inhibits T cell activation by two independent mechanisms [J].

Boncristiano, M ;

Paccani, SR ;

Barone, S ;

Ulivieri, C ;

Patrussi, L ;

Ilver, D ;

Amedei, A ;

D'Elios, MM ;

Telford, JL ;

Baldari, CT .

JOURNAL OF EXPERIMENTAL MEDICINE, 2003, 198 (12) :1887-1897

[10]

Brandtzaeg P., 1994, HDB MUCOSAL IMMUNOLO, P251

← 1 2 3 4 5 6 7 8 9 →